Autolus Therapeutics (AUTL) Non-Current Debt (2017 - 2023)
Autolus Therapeutics posted quarterly Non-Current Debt of $295000.0 for Q3 2023, up 180.95% year-on-year from $105000.0 in Q3 2022, and up 141.8% on a QoQ basis from $122000.0 in Q2 2023.
Autolus Therapeutics (AUTL) has 6 years of Non-Current Debt data on file, last reported at $295000.0 in Q3 2023.
- For the quarter ending Q3 2023, Non-Current Debt rose 180.95% year-over-year to $295000.0; the trailing twelve-month figure through Sep 2023 stood at $295000.0 (up 180.95% YoY), and the FY2022 full-year result was $116000.0, down 9.38% from the prior year.
- Non-Current Debt for Q3 2023 stood at $295000.0, up from $122000.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $295000.0 in Q3 2023 and bottomed at $30000.0 in Q3 2019.
- The 4-year median for Non-Current Debt is $118500.0 (2019), against an average of $127000.0.
- The widest annual swing landed in 2019, when Non-Current Debt sank 92.11%; it then jumped 180.95% in 2023.
- A 4-year view of Non-Current Debt shows it stood at $30000.0 in 2019, then jumped by 326.67% to $128000.0 in 2021, then dropped by 9.38% to $116000.0 in 2022, then soared by 154.31% to $295000.0 in 2023.
- The last three Non-Current Debt figures came in at $295000.0 (Q3 2023), $122000.0 (Q2 2023), and $114000.0 (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 105.94 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.99 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 295,000.00 |
| Sep 30, 2023 | 295,000.00 |
| Jun 30, 2023 | 122,000.00 |
| Jun 30, 2023 | 122,000.00 |
| Mar 31, 2023 | 114,000.00 |
| Mar 31, 2023 | 114,000.00 |
| Dec 31, 2022 | 116,000.00 |
| Dec 31, 2022 | 116,000.00 |
| Sep 30, 2022 | 105,000.00 |
| Sep 30, 2022 | 105,000.00 |
| Jun 30, 2022 | 115,000.00 |
| Jun 30, 2022 | 115,000.00 |
| Mar 31, 2022 | 124,000.00 |
| Mar 31, 2022 | 124,000.00 |
| Dec 31, 2021 | 128,000.00 |
| Dec 31, 2021 | 128,000.00 |
| Sep 30, 2019 | 30,000.00 |
| Sep 30, 2019 | 30,000.00 |
| Jun 30, 2019 | 121,000.00 |
| Jun 30, 2019 | 121,000.00 |
| Dec 31, 2018 | 285,000.00 |
| Dec 31, 2018 | 285,000.00 |
| Sep 30, 2018 | 380,000.00 |
| Sep 30, 2018 | 380,000.00 |
| Sep 30, 2017 | 763,000.00 |
| Sep 30, 2017 | 763,000.00 |